反応式
C([N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[N:15]([CH2:27][CH3:28])[CH:16]=[C:17]([C:19]3[CH:24]=[CH:23][C:22]([F:25])=[C:21]([Cl:26])[CH:20]=3)[N:18]=2)[CH2:10][CH2:9]1)C1C=CC=CC=1.C1(N)C2C(=CC=CC=2N)C=CC=1.ClC(OC(Cl)C)=O>ClCCCl>[ClH:26].[Cl:26][C:21]1[CH:20]=[C:19]([C:17]2[N:18]=[C:14]([CH:11]3[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]3)[N:15]([CH2:27][CH3:28])[CH:16]=2)[CH:24]=[CH:23][C:22]=1[F:25]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
Dissolve 1-Benzyl-4-[4-(3-chloro-4-fluoro-phenyl)-1-ethyl-1H-imidazol-2-yl]-piperidine (263.3 mg, 1.00 equiv; 0.662 mmoles) and 1,8-Naphthalenediamine, N,N,N′,N′-Tetramethyl-(0.05 equiv, 0.033 mmoles, 7.0 mg) in 1,2-Dichloro-ethane (5 mL) and cool in an ice bath. Add 1-chloroethyl chloroformate (1.2 equiv, 0.794 mmol; 0.086 mL). Stir the reaction 10 minutes in an ice bath then heat to reflux for 20 minutes and evaporate to dryness. Dissolve the residue in methanol (5 mL) and reflux for 45 minutes and evaporate to dryness to give 268 mg (0.779 mmol, 118%) 4-[4-(3-chloro-4-fluoro-phenyl)-1-ethyl-1H-imidazol-2-yl]-piperidine hydrochloride.
後処理
- temperaturecool in an ice bath
- customthe reaction 10 minutes in an ice bath
- temperaturethen heat
- temperatureto reflux for 20 minutes
- customevaporate to dryness
- dissolutionDissolve the residue in methanol (5 mL)
- temperaturereflux for 45 minutes
- customevaporate to dryness
出典と根拠
- ORDレコード
- ord-f58beba155f34212b5c2341dbd4e0be3
- 出典データセット
- uspto-grants-2012_01
- 特許番号
- US08093383B2
関連ノート
読み込み中…